Thilo Sarrazin

2 papers and 107 indexed citations i.

About

Thilo Sarrazin is a scholar working on Cell Biology, Small Animals and Industrial relations. According to data from OpenAlex, Thilo Sarrazin has authored 2 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 0 papers in Cell Biology, 0 papers in Small Animals and 0 papers in Industrial relations. Recurrent topics in Thilo Sarrazin’s work include and . Thilo Sarrazin is often cited by papers focused on and . Thilo Sarrazin collaborates with scholars based in and . Thilo Sarrazin's co-authors include and and has published in prestigious journals such as and .

In The Last Decade

Fields of papers citing papers by Thilo Sarrazin

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers citing the papers produced by Thilo Sarrazin. Nodes represent fields, and links connect fields that are likely to share authors. The network helps show where Thilo Sarrazin may publish in the future.

Countries citing papers authored by Thilo Sarrazin

Since Specialization
Citations

This map shows the geographic impact of Thilo Sarrazin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thilo Sarrazin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thilo Sarrazin more than expected).

Rankless by CCL
2025